What We’re Reading: Access to GLP-1 Drugs; ChatGPT Introduces Real-Time Voice Interactions; Medicare Physician Pay Reform
Patients struggle to afford glucagon-like peptide-1 (GLP-1) medications for diabetes; doctors see potential and pitfalls in new ChatGPT model’s humanlike conversations; Medicare payment reform efforts focus on inflation adjustments and payment model overhauls.
Patients Face Medication Shortages, High Costs Amid Growing Demand for GLP-1 Drugs
Patients with diabetes are experiencing supply shortages and insurance hurdles for glucagon-like peptide-1 (GLP-1) agonists, leaving many without access to the medications they need to stay healthy,
Next-Gen ChatGPT’s Real-Time Voice Interactions Could Revolutionize Health Care via Chatbots
OpenAI's latest ChatGPT update, GPT-4o, introduced advanced real-time voice interactions, with potential implications for patient engagement in health care,
Senate Finance Committee Takes Aim at Medicare Physician Pay Reform
The Senate Finance Committee has launched a bipartisan initiative to address declining Medicare physician reimbursements, marking the most significant review in nearly a decade,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025